Cryofocus Medtech (Shanghai) Co., Ltd. (stock code: 06922) released its Monthly Return for Equity Issuer for January 2026. According to the disclosed data, the registered share capital of the company increased to a total of RMB 244,705,000 at the end of the month, comprising 149,033,579 H shares (listed on the Hong Kong Stock Exchange) and 95,671,421 unlisted shares.

The total number of H shares rose by 5,595,000 shares from the previous month, issued to one subscriber at a subscription price of HKD 5.36 per share, finalized on January 30, 2026. An additional 1,865,000 shares had been agreed upon under a separate subscription agreement but were terminated, leading only to the issuance of 5,595,000 new H shares. Following this increase, the company has confirmed that it remains in compliance with the applicable public float requirement.